The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex several-stage organic process. Preliminary routes focused on peptide section coupling, utilizing solid-phase https://esmeeskyq122325.blogspothub.com/39522084/synthesis-and-research-uses-of-retatrutide